会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 4. 发明授权
    • SH2 domain binding inhibitors
    • SH2结构域结合抑制剂
    • US07425537B2
    • 2008-09-16
    • US10517717
    • 2003-06-26
    • Terrence R Burke, Jr.Chang-Qing WeiZhen-Dan ShiYang Gao
    • Terrence R Burke, Jr.Chang-Qing WeiZhen-Dan ShiYang Gao
    • A61K38/12C07K5/12C07K1/00
    • C07F9/6515C07K5/06026C07K5/06191
    • Disclosed are compounds for SH2 domain binding inhibition, for example, a compound of formula (I), wherein R1 is a lipophile; R2, in combination with the phenyl ring, is a phenylphosphate mimic group or a protected phenylphosphate mimic group; R3 is hydrogen, azido, amino, carboxyalkyl, alkoxycarbonylalkyl, aminocarbonylalkyl, or alkylcarbonylamino, wherein the alkyl portion of R3 may be optionally substituted with a substituent selected from the group consisting of halo, hydroxy, carboxyl, amino, aminoalkyl, alkyl, alkoxy, and keto; R6 is a linker; AA is an amino acid; and n is 1 to 6; or a salt thereof. The conformationally compounds provide enhanced binding affinity with SH2 domain protein. Also disclosed are a pharmaceutical compositions and a method for inhibiting an SH2 domain from binding with a phosphoprotein.
    • 公开了用于SH2结构域结合抑制的化合物,例如式(I)的化合物,其中R 1是亲脂体; R 2与苯环组合是苯基磷酸酯模拟基团或被保护的苯基磷酸酯模拟基团; R 3是氢,叠氮基,氨基,羧基烷基,烷氧基羰基烷基,氨基羰基烷基或烷基羰基氨基,其中R 3的烷基部分可以任选地被选自 由卤素,羟基,羧基,氨基,氨基烷基,烷基,烷氧基和酮基组成; R 6是连接体; AA是氨基酸; n为1〜6; 或其盐。 构象化合物提供与SH2结构域蛋白质增强的结合亲和力。 还公开了用于抑制SH2结构域与磷蛋白结合的药物组合物和方法。
    • 6. 发明申请
    • Sh2 domain binding inhibitors
    • Sh2结构域结合抑制剂
    • US20060167222A1
    • 2006-07-27
    • US10517717
    • 2003-06-26
    • Terrence BurkeChang-Qing WeiZhen-DaN ShiYang Gao
    • Terrence BurkeChang-Qing WeiZhen-DaN ShiYang Gao
    • C07K5/12C07D245/02
    • C07F9/6515C07K5/06026C07K5/06191
    • Disclosed are compounds for SH2 domain binding inhibition, for example, a compound of formula (I), wherein R1 is a lipophile; R2, in combination with the phenyl ring, is a phenylphosphate mimic group or a protected phenylphosphate mimic group; R3 is hydrogen, azido, amino, carboxyalkyl, alkoxycarbonylalkyl, aminocarbonylalkyl, or alkylcarbonylamino, wherein the alkyl portion of R3 may be optionally substituted with a substituent selected from the group consisting of halo, hydroxy, carboxyl, amino, aminoalkyl, alkyl, alkoxy, and keto; R6 is a linker; AA is an amino acid; and n is 1 to 6; or a salt thereof. The conformationally compounds provide enhanced binding affinity with SH2 domain protein. Also disclosed are a pharmaceutical compositions and a method for inhibiting an SH2 domain from binding with a phosphoprotein.
    • 公开了用于SH2结构域结合抑制的化合物,例如式(I)的化合物,其中R 1是亲脂体; R 2与苯环组合是苯基磷酸酯模拟基团或被保护的苯基磷酸酯模拟基团; R 3是氢,叠氮基,氨基,羧基烷基,烷氧基羰基烷基,氨基羰基烷基或烷基羰基氨基,其中R 3的烷基部分可以任选地被选自 由卤素,羟基,羧基,氨基,氨基烷基,烷基,烷氧基和酮基组成; R 6是连接体; AA是氨基酸; n为1〜6; 或其盐。 构象化合物提供与SH2结构域蛋白质增强的结合亲和力。 还公开了用于抑制SH2结构域与磷蛋白结合的药物组合物和方法。